openPR Logo
Press release

Uveitis Treatment Market Booming Worldwide with Latest Trend and Future Scope by 2029

09-25-2023 02:08 PM CET | Health & Medicine

Press release from: Orion Market Research

Uveitis Treatment Market Booming Worldwide with Latest Trend

Uveitis treatment market is projected to exhibit a significant growth, at a CAGR of around 6.1%, during the forecast period. The increasing prevalence of uveitis with the rising autoimmune disorders and eye-related disorders has been offering growth to the uveitis treatment market. The growing government initiatives to aware population and provide better healthcare facilities are further creating enormous growth opportunities for the uveitis treatment market in the emerging nations, such as India and China. In addition, the increasing healthcare expenditure and growing medical industry will escalate the market growth during the forecast period. An increasing number of hospitals and ophthalmic clinics in emerging economies are providing immense growth opportunities for the uveitis treatment market.

Such factors have further propelled the need for advanced treatment solutions for uveitis. A new journey can be expected in the uveitis treatment market with the introduction of the novel delivery systems across the globe. This includes the introduction of Iontophoresis for the treatment of anterior uveitis. Iontophoresis refers to the use of an electric current, to propel molecules over the hydrophilic cornea epithelium, which is one of the largest roadblocks to drug penetration in an eye. This expectedly increase the bioavailability of medications, such as steroids, allowing greater reduction in the frequency doses and increase in efficiency, when compared to topical corticosteroids.

Moreover, in May 2018, Clearside Biomedical Inc. introduced novel drug therapy for the treatment of back-of-the-eye diseases. The company announced the attainment for the positive topline results from its new Phase 3 clinical trial of suprachoroidal CLS-TA in patients dealing with macular edema associated with non-infectious uveitis. As per the survey, nearly 47% of patients who were given suprachoroidal CLS-TA for around 12  weeks continuously have gained around 15 letters in best corrected visual acuity ("BCVA"), as measured using the Early Treatment of Diabetic Retinopathy Study ("ETDRS") scale. Moreover, the trial was well tolerated, with no report of any kind of the serious adverse events during the trial.

Intravitreal Sirolimus is another treatment solution available for the uveitis. It is an immunomodulating agent that reduces the number of T-cells and inflammatory cytokines in the patient's body. Oral sirolimus is widely used for the treatment of posterior uveitis; however, due to its certain side effects, the physicians do not recommend. There is an ongoing phase 3 study for the investigation of intravitreal sirolimus for the treatment of non-infectious posterior uveitis treatment. In addition, the intravitreal sirolimus has a lower rate of side effects as compared to intravitreal corticosteroids. Such development in the uveitis treatment solutions will drive the market growth during the forecast period.

To Request a Sample of our Report on Uveitis Treatment Market: https://www.omrglobal.com/request-sample/uveitis-treatment-market

Uveitis Treatment Market-Segmentation

By Disease Type

Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Pan Uveitis

By Treatment Type

Corticosteroids
Immunosuppressant
Monoclonal Antibodies
Cycloplegic Agents
Others (Antiviral and Antibiotics)

A full report of Uveitis Treatment Market is available at: https://www.omrglobal.com/industry-reports/uveitis-treatment-market

Uveitis Treatment Market- Segment by Region

North America          

United States
Canada

Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific   

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Middle East & Africa
Latin America

Company Profiles

AbbVie Inc.
Aldeyra Therapeutics, Inc.
Alimera Sciences, Inc.
Allergan PLC
Bausch Health Companies Inc.
Cadila Pharmaceuticals Ltd.
Clearside Biomedical, Inc.
EyePoint Pharmaceuticals, Inc.
Mylan NV
Novartis AG
Pfizer Inc.
Prometheus Laboratories Inc.
Santen Pharmaceutical Co., Ltd.

Reasons to Buy From us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Uveitis Treatment Market Booming Worldwide with Latest Trend and Future Scope by 2029 here

News-ID: 3222433 • Views:

More Releases from Orion Market Research

Synthetic Ester Lubricants Market Future Prediction Report By 2033
Synthetic Ester Lubricants Market Future Prediction Report By 2033
The Synthetic Ester Lubricants Market was valued at USD 1.3 billion in 2023 and is expected to grow to approximately USD 2.28 billion by 2033, reflecting a CAGR of about 5.8% from 2024 to 2033. Synthetic Ester Lubricants Market Overview Synthetic ester lubricants are derived from chemical processes and offer superior properties compared to conventional mineral oils, including excellent thermal stability, low volatility, and enhanced lubrication characteristics. These attributes make them ideal
Specular Hematite Market Is Booming Worldwide | Latest Study Reveal for the forecast to 2033
Specular Hematite Market Is Booming Worldwide | Latest Study Reveal for the fore …
The Specular Hematite Market was valued at USD 1.8 billion in 2023 and is expected to grow to approximately USD 3.08 billion by 2033, reflecting a CAGR of about 5.5% from 2024 to 2033. Specular Hematite Market Overview The Specular Hematite Market growth is driven by its increasing demand in various industrial applications, particularly in the sectors of construction and automotive, where Specular Hematite is used extensively due to its unique properties.
Compressed Natural Gas (CNG) Truck Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Compressed Natural Gas (CNG) Truck Market Size Analysis, Competitive Insights, L …
The global CNG heavy‐duty truck market was approximately USD 8.5 billion, and by 2033 it is expected to reach around USD 15.2 billion, reflecting a CAGR of 6.0% over the period from 2024 to 2033. Compressed Natural Gas (CNG) Truck Market Overview The CNG truck market-especially in heavy duty applications-is experiencing steady growth, underpinned by increasing environmental regulations and the push towards cleaner transportation. Heavy duty CNG trucks are gaining traction due
Artificial Intelligence (AI) in Precision Medicine Market Rising Demand and Growth Forecast Through 2033
Artificial Intelligence (AI) in Precision Medicine Market Rising Demand and Grow …
In 2023, the global AI in Precision Medicine market was approximately USD 1.73 billion, and by 2033 it is projected to reach around USD 37.01 billion, reflecting a compound annual growth rate (CAGR) of 35.84% from 2024 to 2033. Artificial Intelligence (AI) in Precision Medicine Market Overview The AI in Precision Medicine market is experiencing explosive growth, driven by breakthroughs in deep learning, natural language processing, and context aware computing that enable

All 5 Releases


More Releases for Uveitis

Uveitis Market : An Overview Report
Introduction: Uveitis is an inflammatory condition affecting the uvea, the middle layer of the eye. It can lead to vision impairment or even blindness if left untreated. Uveitis is categorized into different types, including anterior, intermediate, posterior, and panuveitis, depending on the part of the eye affected. The condition can be caused by infections, autoimmune diseases, or trauma. With increasing cases of autoimmune disorders and infectious diseases, the prevalence of uveitis
Uveitis Treatment Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Uveitis Treatment Market Size Projected to Reach USD 2 Billion by 2030, Growing at 6% CAGR Ameco Research is proud to announce the launch of its latest market research report, Uveitis Treatment Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research
Uveitis - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of
Uveitis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of uveitis based
Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures. Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html As per Cochrane,
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &